Onconic Therapeutics (476060.KQ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

37.2x

Market Cap

KRW 767.73B

MomentumView details →

1D Return

+1.85%

YTD Return

−15.91%

RSI (14)

58.3

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

37.2x

Market Cap

KRW 767.73B

RSI (14)

58.3

MomentumView details →

1D Return

+1.85%

YTD Return

−15.91%

ProfitabilityView details →

Gross Margin

54.42%

Net Margin

29.51%

EBITDA Margin

23.07%

ROE (TTM)

28.27%

ROA (TTM)

26.08%

Asset Turnover

0.91x

GrowthView details →

Revenue YoY

+179.26%

EPS YoY

+70.10%

FCF YoY

+488.96%

Revenue CAGR 3Y

+725.25%

EPS CAGR 3Y

+11.02%

EBITDA YoY

+575.13%

EarningsView details →

EPS (Actual)

KRW 83.12

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

KRW 0.00

Avg Surprise (4Q)

—

Rev Surprise

−9.08%

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

11.39x

Quick Ratio

11.39x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

82.17B

Net Income (TTM)

24.25B

Op. CF (TTM)

16.81B

Latest newsMore news →

No recent news for 476060.KQ.

Similar companies

Chabiotech Co.,Ltd.085660.KQ Pharmicell Co., Ltd.005690.KS Medy-Tox Inc.086900.KQ Orum Therapeutics, Inc.475830.KQ GI Innovation, Inc.358570.KQ Green Cross Holdings Corporation005250.KS Find similar companies →

Latest newsMore news →

No recent news for 476060.KQ.